Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.brs.2015.09.003 | DOI Listing |
Case Rep Neurol
September 2021
Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands.
Repetitive transcranial magnetic stimulation (rTMS) is a noninvasive brain stimulation therapy that has become a method of choice for the treatment of several neuropsychiatric disorders such as depression and OCD. It is considered to be a safe and well-tolerated treatment, with only few side effects. The most serious adverse event during any rTMS treatment is the potential induction of a seizure.
View Article and Find Full Text PDFClin Neurophysiol
May 2020
Neuroscience Research Center, Healthy Ageing Research Center and Department of Neurology, Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Taiwan.
Aust J Gen Pract
March 2018
BA, AdvDipMan, Postgraduate student, Australian National Medical School, Gurran, ACT.
Background: Transcranial magnetic stimulation (TMS)is a treatment for major depressive disorder that is otherwise resistant to treatment. Although world-leading research in TMS has been conducted in Australia, where it has had some availability for two decades, there is limited familiarity with the treatment in the general medical community. Availability, however, is increasing.
View Article and Find Full Text PDFJ Child Adolesc Psychopharmacol
September 2016
2 Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota.
Objective: Deep transcranial magnetic stimulation (TMS) with an H-1 coil was recently approved by the U.S. Food and Drug Administration (U.
View Article and Find Full Text PDFBrain Stimul
February 2016
Turku PET Centre, FI-20520 Turku, Finland.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!